Volume 61, Issue 5, Pages (May 2012)

Slides:

Advertisements

Similar presentations

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital

Advertisements

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

A System for Long-term Urodynamic Studies Without Catheters

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 4, Pages (April 2013)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 70, Issue 1, Pages (July 2016)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 59, Issue 4, Pages (April 2011)

Volume 53, Issue 5, Pages (May 2008)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 45, Issue 4, Pages (April 2004)

Volume 57, Issue 5, Pages (May 2010)

Volume 64, Issue 4, Pages (October 2013)

John P. Mulhall, Francesco Montorsi European Urology

Volume 64, Issue 4, Pages (October 2013)

Volume 53, Issue 2, Pages (February 2008)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 59, Issue 3, Pages (March 2011)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 54, Issue 4, Pages (October 2008)

Volume 62, Issue 3, Pages (September 2012)

Volume 70, Issue 3, Pages (September 2016)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 60, Issue 1, Pages (July 2011)

Volume 69, Issue 3, Pages (March 2016)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 69, Issue 2, Pages (February 2016)

Volume 65, Issue 2, Pages (February 2014)

Volume 74, Issue 3, Pages (September 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 58, Issue 5, Pages (November 2010)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital

Volume 63, Issue 3, Pages (March 2013)

Volume 57, Issue 5, Pages (May 2010)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 52, Issue 1, Pages (July 2007)

The Economic Costs of Overactive Bladder in Germany

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 50, Issue 5, Pages (November 2006)

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials David Moher, MSc, Kenneth F Schulz,

Vijay B. Vad, MD, Atul L. Bhat, MD, Yasir Tarabichi

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 74, Issue 6, Pages (December 2018)

Volume 52, Issue 5, Pages (November 2007)

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 72, Issue 2, Pages (August 2017)

Volume 72, Issue 5, Pages (November 2017)

European Urology is “Your” Journal

Volume 68, Issue 2, Pages (August 2015)

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Efficacy of Botulinum Toxin A Intradetrusor Injections for Non-neurogenic Urinary Urge Incontinence: A Randomized Double-Blind Controlled Trial Corrine.

Volume 55, Issue 3, Pages (March 2009)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies David A. Ginsberg, MD, Lynne Kolton.

Volume 52, Issue 6, Pages (December 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Proposed Mechanism for the Efficacy of Injected Botulinum Toxin in the Treatment of Human Detrusor Overactivity Apostolos Apostolidis, Prokar Dasgupta,

Optimal exercise program length for patients with claudication

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 61, Issue 5, Pages 928-935 (May 2012) Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone- Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, Graeme McNeill, Robert Flynn, Thomas E.D. McDermott, Ronald Grainger, John A. Thornhill European Urology Volume 61, Issue 5, Pages 928-935 (May 2012) DOI: 10.1016/j.eururo.2011.10.043 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Sites of botulinum toxin A injection. European Urology 2012 61, 928-935DOI: (10.1016/j.eururo.2011.10.043) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Consolidated Standards of Reporting Trials (CONSORT) flow diagram. European Urology 2012 61, 928-935DOI: (10.1016/j.eururo.2011.10.043) Copyright © 2011 European Association of Urology Terms and Conditions